FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Immigration enforcement officials search Ilhan Omar’s home in pre-dawn raid

Trump’s backyard is quietly transforming into ‘Silicon Valley South’ as wealthy Americans flock in

Jim Justice could shake up West Virginia politics with ‘clash of the titans’ 2028 governor run

Suspect in deadly Philadelphia police ambush faces 76 charges, ordered held without bail

Maduro-linked fugitive nabbed over alleged scheme to cash in on Venezuelans’ basic needs

Pregnant mom just 4 days from giving birth among 8 killed in Pennsylvania massacre: reports

Minnesota homecoming shooting suspect out on bond after gunfire sends football fans fleeing

Trump and Rubio weigh firing Kimberly Guilfoyle as misconduct and donor bailout allegations mount

Quiet part out loud: Anti-Israel mobs want one state called ‘Palestine,’ erasing Israel

Toddler stabbed in face, suspect previously deemed unfit for trial in attacks on 2 children: report

Breaking: Viral Recording Appears to Place Talarico at Ohio Psych Facility During Long Absence Despite Denial

Polls come under scrutiny as Democrats take the lead in midterm elections

Hurricane Isaias’ devastating aftermath comes into focus in striking images

Rescue expert warns FlyDubai hijacking attempt shows US, allies are ‘playing checkers’ against terror threat

‘Fraud’: Rubio Puts Woke So-Called Human Rights Group on Blast for Stunning US-Israel Hypocrisy

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”